Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 2 5Phase 3 4Phase 1/2 2Phase 4 1Phase 2/3 1

Status

Completed 4Recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Prostatic Neoplasms 3Prostate Cancer Metastatic 1Neoplasms 1

Interventions

Cyclophosphamide 297Cisplatin 297Paclitaxel 258Radiotherapy 253Fluorouracil 234Carboplatin 234Docetaxel 231Doxorubicin 212Dexamethasone 164Gemcitabine 155Vincristine 143Etoposide 133Leucovorin 132Capecitabine 129Bevacizumab 129Prednisone 124Rituximab 118Methotrexate 117Cytarabine 108Filgrastim 99Trastuzumab 98Oxaliplatin 96pembrolizumab 81Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Nivolumab 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Completed × XRP6258 × Clear all
NCT02961257 2022-05-12

CABASTY

Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie

Phase 3 Completed
196 enrolled
Genitourinary

Prostate Cancer Metastatic

NCT01308567 2019-06-05

FIRSTANA

Sanofi

Phase 3 Completed
1,168 enrolled 17 charts
Genitourinary

Prostatic Neoplasms

NCT01308580 2017-04-17

PROSELICA

Sanofi

Phase 3 Completed
1,200 enrolled 25 charts
Genitourinary

Prostatic Neoplasms

NCT00417079 2011-03-10

TROPIC

Sanofi

Phase 3 Completed
755 enrolled 19 charts
Genitourinary

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡